Literature DB >> 199051

Supratentorial recurrences of gliomas. Morphological studies in relation to time intervals with oligodendrogliomas.

W Müller, D Afra, R Schröder.   

Abstract

On the basis of a three stage grading system we report 23 stage one recurrent oligodendrogliomas (O 1), and 29 stage two recurrent oligodendrogliomas (O 2). In the O 1 group after the first interval 15 became O 2 and 2 became glioblastomas. Twenty tumours of the O 2 group after the first interval were not changed, three became oligodendroglioma-astrocytomas stage 2, and six became glioblastomas. The time relation for the recurrent phase in the primary O 1 group is calculated as 42 months, and in the primary O 2 group as 22 months, but this is without significance. For the development of malignancy, especially for the change to glioblastoma, a prominent participation by transformed local astrocytes seems to be essential. Postoperative irradiation most probably does not favour malignant change. A prolongation of the expectation of life by radiotherapy is not noticed.

Entities:  

Mesh:

Year:  1977        PMID: 199051     DOI: 10.1007/bf01405237

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  6 in total

1.  Light and electron microscopy of giant-cell glioblastoma.

Authors:  M G Hadfield; S G Silverberg
Journal:  Cancer       Date:  1972-10       Impact factor: 6.860

2.  Rosenthal fibers, birefringent gliofibrillary changes and intracellular homogenous conglomerates in tissue cultures of gliomas.

Authors:  A Gluszcz; L Giernat; K Habryka; J Alwasiak; B Lach; W Papierz
Journal:  Acta Neuropathol       Date:  1971       Impact factor: 17.088

3.  [Statistical contributions concerning the grading of gliomas. 3. Astrocytomas and oligodendrogliomas].

Authors:  R Schröder; W Müller; G Bonis; M Vorreith
Journal:  Acta Neurochir (Wien)       Date:  1970       Impact factor: 2.216

4.  Grouping of supratentorial gliomas according to their dominant biomorphological features.

Authors:  A Gluszcz
Journal:  Acta Neuropathol       Date:  1972       Impact factor: 17.088

5.  A long term study of patients with oligodendrogliomas. Follow-up of 50 cases, including Dr. Harvey Cushing's series.

Authors:  M Roberts; W J German
Journal:  J Neurosurg       Date:  1966-04       Impact factor: 5.115

6.  Supratentorial recurrences of gliomas. Morphological studies in relation to time intervals with astrocytomas.

Authors:  W Müller; D Afra; R Schröder
Journal:  Acta Neurochir (Wien)       Date:  1977       Impact factor: 2.216

  6 in total
  8 in total

1.  DNA in human glioblastomas. A flow-fluorescence cytometrical examination of 96 tumors.

Authors:  F W Spaar; U Spaar
Journal:  Neurosurg Rev       Date:  1990       Impact factor: 3.042

2.  Oligodendrogliomas. Part I: Patterns of growth, histological diagnosis, clinical and imaging correlations: a study of 153 cases.

Authors:  C Daumas-Duport; P Varlet; M L Tucker; F Beuvon; P Cervera; J P Chodkiewicz
Journal:  J Neurooncol       Date:  1997-08       Impact factor: 4.130

3.  Supratentorial recurrences of gliomas. Tissue culture studies with astrocytomas and oligodendrogliomas.

Authors:  L Gazsó; D Afra; W Müller
Journal:  Acta Neuropathol       Date:  1978-11-15       Impact factor: 17.088

4.  Misonidazole and CCNU chemotherapy for recurrent primary brain tumor.

Authors:  D S Fulton; R C Urtasun; S McKinnon; H Tanasichuk
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

5.  Cisplatin and BCNU chemotherapy for anaplastic oligoastrocytomas.

Authors:  A Boiardi; M Eoli; A Salmaggi; B Pollo; I Milanesi; G Broggi; A Silvani
Journal:  J Neurooncol       Date:  2000-08       Impact factor: 4.130

6.  The treatment of cerebral oligodendrogliomas with particular reference to features indicating malignancy: report of seventy-seven cases.

Authors:  M Turgut; K Tahta; O E Ozcan; B Onol
Journal:  Neurosurg Rev       Date:  1998       Impact factor: 3.042

7.  Intermediate filaments and anaplastic change of ENU-induced gliomass: immunohistochemical study with vimentin and astroprotein (GFAP).

Authors:  T Yoshimine; M Maruno; Y Ushio; T Hayakawa; Y Nakajima; H Mogami
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

8.  Supratentorial recurrences of gliomas. Results of reoperations on astrocytomas and oligodendrogliomas.

Authors:  D Afra; W Müller; G Benoist; R Schröder
Journal:  Acta Neurochir (Wien)       Date:  1978       Impact factor: 2.216

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.